Literatur
-
1 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften .Erarbeitung von Leitlinien für Diagnostik und Therapie. Methodische Empfehlungen. Abrufbar unter http://www.uni-duesseldorf.de/WWW/AWMF
-
2
Steinkamp G.
Sauerstofflangzeittherapie - für wen und wie?.
Pneumologie.
2000;
54
309-311
-
3
McSweeny A J, Grant I, Heaton R K, Adams K M, Timms R M.
Life quality of patients with chronic obstructive pulmonary disease.
Arch Intern Med.
1982;
142
473-478
-
4
Okubadejo A A, Paul E A, Jones P W, Wedzicha J A.
Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia.
Thorax.
1996;
51
44-47
-
5
Cotes J E, Gilson J C.
Effect of oxygen on exercise ability in chronic respiratory insufficiency.
Lancet.
1956;
11
872-876
-
6
Burrows D, Earle R H.
Course and prognosis of chronic obstructive lung disease: A prospective study in 200 patients.
N Eng J Med.
1969;
280
397-404
-
7
Nocturnal Oxygen Therapy Trial Group .
Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease.
Ann Intern Med.
1980;
93
391-398
-
8
Medical Research Council Working Party .
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema.
Lancet.
1981;
1
681-686
-
9
Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A.
Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1985;
131
493-498
-
10
Goldberg A, Leger P, Hill N, Criner G.
Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD and nocturnal hypoventilation - a consensus conference report.
Chest.
1999;
116
521-534
-
11
British Thoracic Society .
Guidelines for the management of COPD.
Thorax.
1997;
52
1-28
-
12
American Thoracic Society .
Standards for the diagnosis and care of patients with chronic obstructive disease (COPD) and asthma. Am J Respir Crit.
Care Med.
1995;
152
77-120
-
13
ERS Consensus Statement .
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J.
1995;
8
1398-1420
-
14
Canadian Thoracic Society .
Guidelines for the assessment and management of chronic obstructive pulmonary disease.
CMAJ.
1992;
147
420-428
-
15
Wettengel R, Böhning W, Cegla U, Criée C, Fichter J, Geisler L, Fabel H, Köhler D, Konietzko N, Lindemann H, Magnussen H, Matthys H, Meister R, Morr H, Nolte D, Petro W, Schulze-Werninghaus G, Sill V, Sybrecht G, Wiesner B, Worth H.
Empfehlungen der Deutschen Atemwegsliga zur Behandlung von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem.
Med Klin.
1995;
90
3-7
-
16
Deutsche Gesellschaft für Pneumologie .
Empfehlungen zur Sauerstoff-Langzeit-Therapie bei schwerer chronischer Hypoxämie.
Pneumologie.
1993;
47
2-4
-
17
Górecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J.
Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia.
Thorax.
1997;
52
674-679
-
18
Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Ehrhart M, Schott R, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R, Moutinho dos S antos.
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients.
Eur Respir J.
1999;
14
1002-1008
-
19
Köhler D, Criée C P, Raschke F. . Deutsche Gesellschaft für Pneumologie, Deutsche Gesellschaft für Schlafmedizin, Arbeitsgruppe Nächtliche Atmungs- und Kreislaufstörungen, Arbeitskreis Heim- und Langzeitbeatmung .
Leitlinien zur häuslichen Sauerstoff- und Heimbeatmungstherapie.
Medizinische Klinik.
1997;
92
2-6
-
20 Agency for Health Care Policy and Research .Cardiac rehabilitation: clinical practice guidelines, No. 17. US Dept of Health and Human Services 1995
-
21
Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu J M . for the observatory group of ANTADIR .
Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation.
Chest.
1996;
109
741-749
-
22
Dubois P, Jamart J, Machiels J, Smeets F, Lulling J.
Prognosis of severely hypoxemic patients receiving long-term oxygen therapy.
Chest.
1994;
105
469-474
-
23
Aida A, Miyamoto K, Bishimura M, Aiba M, Kira S, Kawakami Y . and the respiratory failure research group in Japan .
Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy.
Am J Respir Crit Care Med.
1998;
158
188-193
-
24
Meecham Jones D J, Paul E A, Jones P W, Wedzicha J A.
Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD: a randomized controlled study.
Am J Respir Crit Care.
1995;
152
538-544
-
25
Lock S H, Blower G, Prynne M, Wedzicha J A.
Comparison of liquid and gaseous oxygen for domiciliary portable use.
Thorax.
1992;
47
98-100
-
26
Bradley B L, Garner A E, Billiu D, Mestas J M, Forman J.
Oxygen-assisted exercise in chronic obstructive lung disease: the effect on exercise capacity and arterial blood gas tension.
Am Rev Respir Dis.
1978;
118
239-243
-
27
Bye P TP, Esau S A, Levy R D. et al .
Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation.
Am Rev Respir Dis.
1985;
132
236-240
-
28
Dean N C, Brown J K, Himelman R B, Doherty J J, Gold W M, Stulbarg M S.
Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia.
Am Rev Respir Dis.
1992;
146
941-945
-
29
Beaumont A, Cockroft A, Guz A.
A self paced treadmill walking test for breathless patients.
Thorax.
1985;
40
459-464
-
30
Kirsten D K, Jörres R, Magnussen H.
Indikation und Durchführung des 6 Minuten Laufbandtestes in der Pneumologie.
Pneumologie.
1997;
51
33-35
-
31
Revill S M, Morgan M D, Singh S J, Williams J, Hardman A E.
The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic pulmonary disease.
Thorax.
1999;
54
213-222
-
32
Leach R M, Davidson A C, Chinn S, Twort C HC, Cameron I R, Bateman N T.
Portable liquid oxygen and exercise ability in severe respiratory disability.
Thorax.
1992;
47
781-789
-
33
Strandling J R, Lane D J.
Nocturnal hypoxaemia in chronic obstructive pulmonary disease.
Clin Sci.
1983;
64
213-222
-
34
Vos P JE, Folgering H, van Herwaarden C LA.
Predictors of nocturnal hypoxaemia (mean SaO2 < 90 %) in normoxic and mildly hypoxic patients with COPD.
Eur Respir J.
1995;
18
74-77
-
35
Mulloy E, McNicholas W.
Ventilation and gas exchange during sleep and exercise in severe COPD.
Chest.
1996;
109
387-394
-
36
Fletcher E C, Luckett R A, Goodnight-White S, Miller C M, Qian W, Costarangos-Galarza C.
A double-blind trial of nocturnal supplemental oxygen for sleep desaturation on patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg.
Am Rev Respir Dis.
1992;
145
1070-1076
-
37
Ström K, Boe J.
Quality assessment and predictors of survival in long-term domiciliary oxygen therapy.
Eur Respir J.
1991;
4
50-58
-
38
Ström K, Boman G . the Swedish society of chest medicine .
Long-term oxygen therapy in parenchymal lung disease: an analysis of survival.
Eur Respir J.
1993;
6
1264-1270
-
39
Bye P TP, Anderson S D, Woolcock A J. et al .
Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen.
Am Rev Respir Dis.
1982;
126
1005-1012
-
40
Harris-Eze A O, Sridhar G, Clemens R E, Gallagher C G, Marciniuk D D.
Oxygen improves maximal exercise performance in interstitial lung disease.
Am J Respir Crit Care Med.
1994;
150
1616-1622
-
41
Harris-Eze A O, Sridhar G, Clemens R E, Zintel T A, Gallagher C G, Marciniuk D D.
Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease.
Am J Respir Crit Care Med.
1996;
154
994-1001
-
42
Zimman R, Corey M, Coates A L, Canny G J, Connolly J, Levison H, Beaudry P H.
Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients.
J Pediatr.
1989;
114
368-377
-
43
Fraser K L, Tullis D E, Sasson Z, Hyland R H, Thornley K S, Hanly P J.
Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia.
Chest.
1999;
115
1321-1328
-
44
Marcus C L, Bader D, Stabile M W, Wang C I, Osher A B, Keens T G.
Supplemental oxygen and exercise performance in patients with cystic fibrosis with severe pulmonary disease.
Chest.
1992;
101
52-57
-
45
Nixon P A, Orenstein D M, Curtis S E, Ross E A.
Oxygen supplementation during exercise in cystic fibrosis.
Am Rev Respir Dis.
1990;
142
807-811
-
46
Mesa J, Celli B, Riesco J. et al .
Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall disease.
Chest.
1997;
112
207-213
-
47
Gay P, Edmonds L.
Severe hypercapnia after low-flow oxygen therapy in patients with neuromuscular disease and diaphragmatic dysfunction.
Mayo Clin Proc.
1995;
70
327-330
-
48
Houston T P, Elster A B.
The US-Preventive Task Force guide to clinical prevention services. AMA Council on Scientific Affairs.
Am J Prev Med.
1998 May;
14 (4)
374-376
-
49
Irvin R S, Boulet L P, Cloutier M M, Fuller R, Gold P, Hoffstein V, Ing A J, McCool D, O’Byrne P, Poe R H, Prakash U BS, Pratter M R, Rubin B K.
Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians.
Chest.
1998;
114
S133-S181
-
50
Pitkin A D, Roberts C M, Wedzicha J A.
Arterialised earlobe blood gas analysis: an underused technique.
Thorax.
1994;
49
364-366
-
51
Cahill C K, Heath J.
Sterile water used for humidification in low-flow oxygen therapy: Is it necessary?.
Am J Infect Control.
1990;
18
13-17
-
52
Tausendpfund C, Petro W.
Sauerstofflangzeittherapie: Welche Applikationsform ist empfehlenswert.
Pneumologie.
1996;
50
260-267
-
53
Köhler D, Knoch M, Sommerfeld S C, Müller H.
A new oxygen applicator for simultaneous mouth and nose breathing.
Chest.
1993;
103
1157-1160
-
54
Kampelmacher M J, Deenstra M, van Kesteren R G, Melissant C F, Douze J MC, Lammers J WJ.
Transtracheal oxygen therapy: an effective and safe alternative to nasal oxygen administration.
Eur Respir J.
1997;
10
828-833
-
55 Crockett A J, Moss J R, Cranston J M, Alpers J H. Domiciliary oxygen for chronic obstructive pulmonary disease. Issue 1. The Cochrane Library 2000
-
56
Veale D, Chaielleuc E, Taydard A, Cardinaud J P.
Characteristics and survival of patients prescibed long-term oxygen therapy outside prescription guidelines.
Eur Respir J.
1998;
12
780-784
-
57
Pellitier-Fleury N, Lanoe J L, Fleury B.
The cost of treating COPD patients with long-term oxygen therapy in a French population.
Chest.
1996;
110 (2)
411-416
-
58
Andersson A, Strom K, Brodin H, Alton M, Boman G.
Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis.
Eur Respir J.
1998;
12 (6)
1284-1289
-
59
Crockett A J, Cranston J M, Moss J R.
Effects of long-term oxygen therapy on quality of life and survival in chronic airflow limitation.
Monaldi Arch Chest Dis.
1999;
54 (2)
193-196
-
60
Borak J, Sliwinski P, Tobiasz M.
Psychological status of COPD patients before and after one year of long-term oxygen therapy.
Monaldi Arch Chest Dis.
1996;
51 (1)
7-11
-
61
Janssens J P, Rochat T, Frey J G.
Health-related quality of life in patients under long-term oxygen therapy: a home-based descriptive study.
Respir Med.
1997;
91 (10)
592-602
-
62
Hoang T TH, Guillemin F, Cornette A.
Health-related quality of life in long-term oxygen-treated chronic obstructive pulmonary disease patients.
Lung.
1997;
175 (1)
63-71
-
63
Monso E, Fiz J M, Izquierdo J.
Quality of life in severe chronic obstructive pulmonary disease: correlation with lung and muscle function.
Respir Med.
1998;
92
221-227
Prof. Dr. med. H. Magnussen
Krankenhaus Großhansdorf
Zentrum für Pneumologie und Thoraxchirurgie
Wöhrendamm 80
22927 Großhansdorf
Email: E-mail: magnussen@pulmoresearch.de
